Dr. Paryani’s Research Publications | Tampa Oncology and Proton

Published Research by Dr. Paryani

Dr. Paryani gives a talk on rare tumors at Acibadem Hospital in Instanbul, Turkey.

Dr. Paryani gives a talk on rare tumors at Acibadem Hospital in Instanbul, Turkey.

Google Scholar Articles

Multimodality Local Therapy for Retroperitoneal Sarcoma

Soft-tissue sarcomas of the retroperitoneum are rare tumors comprising less than 1% of all malignancies. Although surgery continues as the mainstay of treatment, the large size of these tumors coupled with their proximity to critical structures make resection with wide margins difficult to achieve. The role and timing of radiotherapy are controversial. This study updates...

Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy

To update a previously proposed prognostic scoring system that predicts risk of biochemical recurrence (BCR) after salvage radiation therapy (SRT) for recurrent prostate cancer when using additional patients and a PSA value of 0.2 ng/ml and rising as the definition of BCR. We included 577 patients who received SRT for a rising PSA following radical...

The incidence of fat necrosis in balloon-based breast brachytherapy

To investigate the incidence of and potential risk factors for fat necrosis in high dose-rate (HDR) balloon-based breast brachytherapy (BBB).

Nitesh N. Paryani’s research while affiliated with Mayo Foundation for Medical Education and Research and other places

Previous reports have shown a positive association between serum calcium level and prostate cancer mortality. However, there is no data regarding whether higher serum calcium levels are associated with increased risk of biochemical recurrence (BCR) following salvage radiation therapy (SRT) for prostate cancer. Herein, we evaluate the association between pretreatment serum calcium levels and BCR...

Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II NoneSmall Cell Lung Cancer: The Mayo Clinic Experience

Disease control was excellent for patients who received stereotactic body radiotherapy for early-stage non-small cell lung cancer, and this series represents the largest single institutional experience from the United States on stereotactic body radiotherapy for early stage inoperable non-small cell lung cancer.

Extranodal Rosai-Dorfman disease of the bone treated with surgery and radiotherapy

Rosai-Dorfman disease (RDD) is a rare, benign histiocyte disorder originally described by Rosai and Dorfman in 1969 as sinus histiocytosis with massive lymphadenopathy. It most typically presents as massive, painless cervical lymphadenopathy, and it is most often found in adolescents and young adults. Extranodal involvement is a common feature of RDD and may occur in...

Late toxicity from salvage radiation therapy for prostate cancer: intensity-modulated radiation therapy vs. 3D-conformal radiation therapy

This study aims to compare late toxicity in patients undergoing salvage radiation therapy (SRT) for a detectable prostate-specific antigen level after radical prostatectomy between those who received low-dose three-dimensional-conformal radiation therapy (3D-CRT), high-dose 3D-CRT and intensity-modulated radiation therapy (IMRT).

Multimodality therapy for locally advanced esophageal cancer.

The current standard of care for locally advanced esophageal cancer includes chemoradiotherapy with or without surgery. Radiation is usually delivered via a 3D technique. IMRT has been utilized in the treatment of multiple tumors and demonstrated similar efficacy while offering the possibility of decreased toxicity.

(P101) Does Maximum SUV From F-18 PET Scan Predict Outcomes for Early-Stage Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (SBRT)?

Prior studies have shown mixed results regarding the predictive value of positron emission tomography (PET) scan following definitive treatment of early-stage lung cancers. The primary outcome of this study was to evaluate the association of maximum standard uptake value (SUVmax) on PET scan with recurrence and survival in patients with lung cancer who were treated...

Comparison of Three-Dimensional (3D) Conformal Proton Radiotherapy (RT), 3D Conformal Photon RT, and Intensity-Modulated RT for Retroperitoneal and Intra-Abdominal Sarcomas

To compare three-dimensional conformal proton radiotherapy (3DCPT), intensity-modulated photon radiotherapy (IMRT), and 3D conformal photon radiotherapy (3DCRT) to predict the optimal RT technique for retroperitoneal sarcomas.